Back

Ultrasound Activated Nanobubbles Induce Durable Systemic Antitumor Immunity

Bhalotia, A.; Nittayacharn, P.; Hutchinson, D. W.; Cheplyansky, A.; Takizawa, K. H.; Nidhiry, A.; Hariharan, S.; Novak, A.; Iyer, A.; Mehta, M.; Kosmides, T.; Perera, R.; Hwang, I. M.; Exner, A. A.; Karathanasis, E.

2026-03-27 bioengineering
10.64898/2026.03.25.714247 bioRxiv
Show abstract

Clinical outcomes in aggressive breast cancer vary widely, in part because the tumor microenvironment is structured to exclude immune infiltration. Low antigen load, dysfunctional antigen-presenting cells, T cell exclusion and exhaustion, and a stiff extracellular matrix that physically restricts immune cell trafficking work together to form a suppressive barrier that current immunotherapies struggle to overcome. We addressed this barrier using ultrasound (US)-activated nanobubbles (NBs), a drug-free intervention based on perfluoropropane-filled nanoparticles. The size and deformable phospholipid shell enable NBs to achieve deep tumor penetration and a uniform distribution throughout the entire tumor. Upon ultrasound activation, NBs generate localized mechanical forces that restore extracellular matrix elasticity, disrupt tumor transport barriers, and drive HMGB1 release, re-engaging endogenous antitumor immunity without pharmacological agents. In a syngeneic triple-negative breast cancer model, US-NB treatment depleted immunosuppressive myeloid cells 3-fold within 3 hours, followed by a greater than 5-fold increase in the ratio of antigen-experienced to suppressive T cells at 48 hours. US-NB drives rapid infiltration of CD4+ and CD8+ T cells within 48 hours. US-NB treatment achieved an 85% cure rate in the D2A1 model; cured animals maintained durable systemic immune memory, rejecting both local and systemic tumor rechallenge. Consistent therapeutic benefit was observed in a luminal B-like mammary tumor model (E0771), supporting activity across breast cancer subtypes. These results establish US-NB mechanical immunomodulation as a drug-free therapeutic strategy capable of generating robust and durable antitumor immunity, acting through biophysical tissue properties rather than tumor-specific molecular targets. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=90 SRC="FIGDIR/small/714247v1_ufig1.gif" ALT="Figure 1"> View larger version (56K): org.highwire.dtl.DTLVardef@b1ed5forg.highwire.dtl.DTLVardef@1572a98org.highwire.dtl.DTLVardef@1ad6906org.highwire.dtl.DTLVardef@1ca1b36_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Advanced Materials
53 papers in training set
Top 0.1%
18.4%
2
Advanced Science
249 papers in training set
Top 0.6%
14.6%
3
Advanced Functional Materials
41 papers in training set
Top 0.2%
10.0%
4
Advanced Healthcare Materials
71 papers in training set
Top 0.5%
4.3%
5
Nano Letters
63 papers in training set
Top 0.6%
4.3%
50% of probability mass above
6
Nature Nanotechnology
30 papers in training set
Top 0.3%
3.9%
7
Nature Communications
4913 papers in training set
Top 40%
3.6%
8
ACS Nano
99 papers in training set
Top 1%
3.6%
9
Science Advances
1098 papers in training set
Top 11%
2.3%
10
Journal of Controlled Release
39 papers in training set
Top 0.4%
2.3%
11
Nature Materials
21 papers in training set
Top 0.3%
2.1%
12
Cell Reports Medicine
140 papers in training set
Top 3%
1.9%
13
Bioengineering & Translational Medicine
21 papers in training set
Top 0.4%
1.7%
14
Biomaterials
78 papers in training set
Top 0.6%
1.7%
15
Journal of the American Chemical Society
199 papers in training set
Top 3%
1.7%
16
Nature Biotechnology
147 papers in training set
Top 5%
1.5%
17
Small
70 papers in training set
Top 0.7%
1.3%
18
Nature Biomedical Engineering
42 papers in training set
Top 1%
1.3%
19
Angewandte Chemie International Edition
81 papers in training set
Top 3%
1.2%
20
Theranostics
33 papers in training set
Top 0.9%
1.2%
21
Cell Reports
1338 papers in training set
Top 28%
1.2%
22
Cell Systems
167 papers in training set
Top 11%
0.8%
23
Advanced Therapeutics
15 papers in training set
Top 0.4%
0.8%
24
APL Bioengineering
18 papers in training set
Top 0.4%
0.7%
25
Bioactive Materials
18 papers in training set
Top 0.8%
0.7%
26
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 46%
0.7%
27
Cancer Immunology, Immunotherapy
11 papers in training set
Top 0.5%
0.6%
28
Biomacromolecules
25 papers in training set
Top 0.5%
0.6%
29
eLife
5422 papers in training set
Top 62%
0.6%
30
iScience
1063 papers in training set
Top 38%
0.6%